varunadi churna in renal stone

Randomised open controlled clinical study to evaluate the efficacy of varunadi churna in mutrashmari with special reference to urolithiasis

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/040976

Enrollment

Registered

2022-03-10

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: Varunadi churna: Varunadi churna 3gm TDS for 15 days Control Intervention1: Tab outocal: Tab outocal 500 mg BD for 15 days

Eligibility

Inclusion criteria

Inclusion criteria: Predignosed patient with clinical features and USG showing calclus size 4-8 mm songle or multiple will be taken for treatment Calclus present in kidney/ureter/bladder

Exclusion criteria

Exclusion criteria: Patient who were containdicated for paneeya kshara Any malignancy Any systemic disease

Design outcomes

Primary

Measure	Time frame
Decrease in stone sizeTimepoint: 18 months	—

Secondary

Measure	Time frame
Decrease in symptoms like pain burning mituration dysuriaTimepoint: 18 months	—

Countries

India

Contacts

Public ContactShahal Yuvraj Bhosale

Yashwant Ayurvedic Medical College PGT and RC kodoli

drsrinivast@gmail.com9503147698

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026